Literature DB >> 21724851

Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity.

Hilla Ovadia1, Yulia Haim, Ori Nov, Orna Almog, Julia Kovsan, Nava Bashan, Moran Benhar, Assaf Rudich.   

Abstract

Protein S-nitrosylation is a reversible protein modification implicated in both physiological and pathophysiological regulation of protein function. In obesity, skeletal muscle insulin resistance is associated with increased S-nitrosylation of insulin-signaling proteins. However, whether adipose tissue is similarly affected in obesity and, if so, what are the causes and functional consequences of increased S-nitrosylation in this tissue are unknown. Total protein S-nitrosylation was increased in intra-abdominal adipose tissue of obese humans and in high fat-fed or leptin-deficient ob/ob mice. Both the insulin receptor β-subunit and Akt were S-nitrosylated, correlating with body weight. Elevated protein and mRNA expression of inducible NO synthase and decreased protein levels of thioredoxin reductase were associated with increased adipose tissue S-nitrosylation. Cultured differentiated pre-adipocyte cell lines exposed to the NO donors S-nitrosoglutathione (GSNO) or S-nitroso-N-acetylpenicillamine exhibited diminished insulin-stimulated phosphorylation of Akt but not of GSK3 nor of insulin-stimulated glucose uptake. Yet the anti-lipolytic action of insulin was markedly impaired in both cultured adipocytes and in mice injected with GSNO prior to administration of insulin. In cells, impaired ability of insulin to diminish phosphorylated PKA substrates in response to isoproterenol suggested impaired insulin-induced activation of PDE3B. Consistently, increased S-nitrosylation of PDE3B was detected in adipose tissue of high fat-fed obese mice. Site-directed mutagenesis revealed that Cys-768 and Cys-1040, two putative sites for S-nitrosylation adjacent to the substrate-binding site of PDE3B, accounted for ∼50% of its GSNO-induced S-nitrosylation. Collectively, PDE3B and the anti-lipolytic action of insulin may constitute novel targets for increased S-nitrosylation of adipose tissue in obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21724851      PMCID: PMC3162403          DOI: 10.1074/jbc.M111.235945

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Hormone sensitive phosphodiesterase of liver and adipose tissue.

Authors:  E G Loten
Journal:  Int J Biochem       Date:  1991

Review 2.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

3.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

Review 4.  Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.

Authors:  V C Manganiello; T Murata; M Taira; P Belfrage; E Degerman
Journal:  Arch Biochem Biophys       Date:  1995-09-10       Impact factor: 4.013

5.  A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain.

Authors:  Susan Kane; Hiroyuki Sano; Simon C H Liu; John M Asara; William S Lane; Charles C Garner; Gustav E Lienhard
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

6.  Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes.

Authors:  Takeshi Nishikawa; Takayuki Sasahara; Shinsuke Kiritoshi; Kazuhiro Sonoda; Takahumi Senokuchi; Tomoko Matsuo; Daisuke Kukidome; Nakayasu Wake; Takeshi Matsumura; Nobuhiro Miyamura; Michiharu Sakakida; Hideki Kishikawa; Eiichi Araki
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

7.  Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages.

Authors:  J B Weinberg; M A Misukonis; P J Shami; S N Mason; D L Sauls; W A Dittman; E R Wood; G K Smith; B McDonald; K E Bachus
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

8.  Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity.

Authors:  Giovanna Scapin; Sangita B Patel; Christine Chung; Jeffrey P Varnerin; Scott D Edmondson; Anthony Mastracchio; Emma R Parmee; Suresh B Singh; Joseph W Becker; Lex H T Van der Ploeg; Michael R Tota
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

9.  Regulation of the nitric oxide system in human adipose tissue.

Authors:  Stefan Engeli; Jürgen Janke; Kerstin Gorzelniak; Jana Böhnke; Nila Ghose; Carsten Lindschau; Friedrich C Luft; Arya M Sharma
Journal:  J Lipid Res       Date:  2004-07-01       Impact factor: 5.922

10.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Authors:  J S Stamler; D I Simon; J A Osborne; M E Mullins; O Jaraki; T Michel; D J Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

View more
  19 in total

1.  S-nitrosylation of fatty acid synthase regulates its activity through dimerization.

Authors:  Min Sik Choi; Ji-Yong Jung; Hyoung-June Kim; Mi Ra Ham; Tae Ryong Lee; Dong Wook Shin
Journal:  J Lipid Res       Date:  2016-02-05       Impact factor: 5.922

Review 2.  Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease.

Authors:  Puneet Anand; Jonathan S Stamler
Journal:  J Mol Med (Berl)       Date:  2012-02-24       Impact factor: 4.599

Review 3.  S-nitrosylation: specificity, occupancy, and interaction with other post-translational modifications.

Authors:  Alicia M Evangelista; Mark J Kohr; Elizabeth Murphy
Journal:  Antioxid Redox Signal       Date:  2013-01-04       Impact factor: 8.401

Review 4.  Protein S-Nitrosylation: Determinants of Specificity and Enzymatic Regulation of S-Nitrosothiol-Based Signaling.

Authors:  Colin T Stomberski; Douglas T Hess; Jonathan S Stamler
Journal:  Antioxid Redox Signal       Date:  2018-01-10       Impact factor: 8.401

Review 5.  The manifold roles of protein S-nitrosylation in the life of insulin.

Authors:  Hua-Lin Zhou; Richard T Premont; Jonathan S Stamler
Journal:  Nat Rev Endocrinol       Date:  2021-11-17       Impact factor: 47.564

Review 6.  Targeting the NO/superoxide ratio in adipose tissue: relevance to obesity and diabetes management.

Authors:  Aleksandra Jankovic; Aleksandra Korac; Biljana Buzadzic; Ana Stancic; Vesna Otasevic; Péter Ferdinandy; Andreas Daiber; Bato Korac
Journal:  Br J Pharmacol       Date:  2016-05-15       Impact factor: 8.739

7.  Targeted disruption of inducible nitric oxide synthase protects against aging, S-nitrosation, and insulin resistance in muscle of male mice.

Authors:  Eduardo R Ropelle; José R Pauli; Dennys E Cintra; Adelino S da Silva; Cláudio T De Souza; Dioze Guadagnini; Bruno M Carvalho; Andrea M Caricilli; Carlos K Katashima; Marco A Carvalho-Filho; Sandro Hirabara; Rui Curi; Lício A Velloso; Mario J A Saad; José B C Carvalheira
Journal:  Diabetes       Date:  2012-09-18       Impact factor: 9.461

8.  Aging and insulin resistance: just say iNOS.

Authors:  Joseph L Evans; Ira D Goldfine
Journal:  Diabetes       Date:  2013-02       Impact factor: 9.461

Review 9.  Influence of gut microbiota on subclinical inflammation and insulin resistance.

Authors:  Bruno Melo Carvalho; Mario Jose Abdalla Saad
Journal:  Mediators Inflamm       Date:  2013-06-12       Impact factor: 4.711

10.  Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.

Authors:  Ori Nov; Hagit Shapiro; Hilla Ovadia; Tanya Tarnovscki; Irit Dvir; Elad Shemesh; Julia Kovsan; Ilan Shelef; Yaron Carmi; Elena Voronov; Ron N Apte; Eli Lewis; Yulia Haim; Daniel Konrad; Nava Bashan; Assaf Rudich
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.